ATYR FY 2020 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+2377.5% YoY

Gross Profit

-$7M-65.4% margin

Operating Income

-$16M-152.2% margin

Net Income

-$16M-155.2% margin

EPS (Diluted)

$-1.77

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$39M

Total Liabilities

$7M

Stockholders' Equity

$32M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$422,000	+2377.5%
Gross Profit	-$7M	-$14M	+49.8%
Operating Income	-$16M	-$23M	+30.8%
Net Income	-$16M	-$24M	+31.3%